News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cerus Corporation (CERS) Reports Fourth Quarter And Year-End 2013 Results


2/26/2014 6:50:12 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Cerus Corporation (NASDAQ: CERS) today announced financial results for the fourth quarter and year ended December 31, 2013.

"The coming year will be a pivotal one for Cerus, in which we anticipate a possible second-half approval decision for INTERCEPT plasma in the United States, and prepare for a possible INTERCEPT platelet approval decision in 2015,“ said William "Obi" Greenman, president and chief executive officer of Cerus Corporation.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES